The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Person-specific contribution of neuropathologies to cognitive loss in old age
Open accessAbstract
Objective: Mixed neuropathologies are the most common cause of dementia at the population level, but how different neuropathologies contribute to cognitive decline at the individual level remains unknown. We quantified the contribution of 9 neuropathologies to cognitive loss at an individual level. Methods: Participants (n = 1,079) came from 2 longitudinal clinical–pathologic studies of aging. All completed 2 + cognitive evaluations (maximum = 22), died, and underwent neuropathologic examinations to identify Alzheimer disease (AD), other neurodegenerative diseases, and vascular pathologies. Linear mixed models examined associations of neuropathologies with cognitive decline and estimated the proportion of cognitive loss accounted for by each neuropathology at a person‐specific level. Results: Neuropathology was ubiquitous, with 94% of participants having 1+, 78% having 2+, 58% having 3+, and 35% having 4+. AD was most frequent (65%) but rarely occurred in isolation (9%). Remarkably, >230 different neuropathologic combinations were observed, each of which occurred in <6% of the cohort. The relative contributions of specific neuropathologies to cognitive loss varied widely across individuals. Although AD accounted for an average of about 50% of the observed cognitive loss, the proportion accounted for at the individual level ranged widely from 22% to 100%. Lewy bodies and hippocampal sclerosis also had potent effects, but again their impacts varied at the person‐specific level. Interpretation: There is much greater heterogeneity in the comorbidity and cognitive impact of age‐related neuropathologies than currently appreciated, suggesting an urgent need for novel therapeutic approaches that embrace the complexity of disease to combat cognitive decline in old age. Ann Neurol 2018;83:74–83
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Studies suggest that mixed dementia is the norm, not just for those diagnosed with Alzheimer's dementia but also for those diagnosed with other types of dementia.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [37]
The cited source says what the claim attributes to it.
In the citing paper
“As inquiries move in this direction—through the use of PET imaging, cerebrospinal fluid, blood, or autopsy—it is important to note that mixed dementia is the most common type of dementia and that a diverse set of neuropathologies may contribute to the clinical syndrome that we diagnose as dementia (Boyle et al. 2018; Brenowitz et al. 2017; Power et al. 2018b).”
From Exposure to Air Pollution in Relation to Risk of Dementia and Related Outcomes: An Updated Systematic Review of the Epidemiological Literature (2021) · cites this paper as Boyle et al. 2018
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A further RCT of cognitively stimulating activities for people with delirium in dementia did not improve the delirium.293”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [293]
Experimental — accuracy not yet measuredIn the citing paper
“First, it captures all the factors affecting cognition, including diverse pathologies as well as biological mechanisms independent of pathologies4–6.”
From Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age (2019) · cites this paper as [5]
In the citing paper
“Second, it likely captures co-occurring disease processes and co-occurring age-related pathologies, which are known to be prevalent in the brains of aged individuals4,5.”
From Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age (2019) · cites this paper as [5]
In the citing paper
“However, pathologies such as β-amyloid plaques, neurofibrillary tangles, microinfarct, macroinfarct, and Lewy bodies together capture only about 41% of the variance in cognitive trajectory, leaving 59% unexplained5,7.”
From Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age (2019) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
Self-citationThe neuropathology of probable Alzheimer disease and mild cognitive impairment
Schneider, J. A., Arvanitakis, Z., Leurgans, S. E., & Bennett, D. A. (2009) · Annals of Neurology · doi:10.1002/ana.21706 · Cited by 935
Self-citationOverview and Findings from the Rush Memory and Aging Project
Bennett, D. A., Schneider, J. A., Buchman, A. S., Barnes, L. L., Boyle, P. A., & Wilson, R. S. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322663 · Cited by 849
Self-citationIndividual differences in rates of change in cognitive abilities of older persons.
Wilson, R. S., Beckett, L. A., Barnes, L. L., Schneider, J. A., Bach, J., Evans, D. A., & Bennett, D. A. (2002) · Psychology and Aging · doi:10.1037/0882-7974.17.2.179 · Cited by 842
Self-citationImpact of multiple pathologies on the threshold for clinically overt dementia
Kapasi, A., DeCarli, C., & Schneider, J. A. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1717-7 · Cited by 739
Self-citationOverview and Findings from the Religious Orders Study
Bennett, D. A., Schneider, J. A., Arvanitakis, Z., & Wilson, R. S. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322573 · Cited by 656
Self-citationArvanitakis, Z., Capuano, A. W., Leurgans, S. E., Bennett, D. A., & Schneider, J. A. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30029-1 · Cited by 581
Self-citationCerebral amyloid angiopathy and cognitive outcomes in community-based older persons
Boyle, P. A., Yu, L., Nag, S., Leurgans, S., Wilson, R. S., Bennett, D. A., & Schneider, J. A. (2015) · Neurology · doi:10.1212/wnl.0000000000002175 · Cited by 423
Self-citationTDP-43 stage, mixed pathologies, and clinical Alzheimer’s-type dementia
James, B. D., Wilson, R. S., Boyle, P. A., Trojanowski, J. Q., Bennett, D. A., & Schneider, J. A. (2016) · Brain · doi:10.1093/brain/aww224 · Cited by 407
Self-citationMuch of late life cognitive decline is not due to common neurodegenerative pathologies
Boyle, P. A., Wilson, R. S., Yu, L., Barr, A. M., Honer, W. G., Schneider, J. A., & Bennett, D. A. (2013) · Annals of Neurology · doi:10.1002/ana.23964 · Cited by 323
Self-citation
Cited by
Sorted by citations
Items 401–500 of 508
Piqueras-Sanchez, C., Esteve‐Pastor, M. A., Moreno-Fernandez, J., Soler‐Espejo, E., Rivera‐Caravaca, J. M., Roldán, V., & Marín, F. R. (2024) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2024.2379413 · Cited by 1
Biomarkers for Alzheimer's Disease
Panwar, D., Sharma, P., Sharma, S., Malik, M., & Kaur, J. (2024) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/979-8-3693-6442-0.ch003 · Cited by 1
Pathophysiology of Alzheimer’s Disease: Herbal Neurogenesis and Synthetic Molecular Interventions
Kumar, A., Kumar, M., Verma, A., Joshi, R., Bidlan, M., & Singh, R. (2025) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-025-00304-2 · Cited by 2
“The prevalence of alzheimer’s all-cause dementia is linked, with AD is a highly prevalent cause of dementia, among others factors can also lead to dementia [19, 20], certain cerebrovascular or neurological diseases, especially in elderly patients.”
Aortic Stiffness and Alzheimer’s Disease: The Medin Connection
Triposkiadis, F. K., Xanthopoulos, A. V., Boudoulas, H. K., & Brutsaert, D. L. (2025) · Biomolecules · doi:10.3390/biom15081148 · Cited by 2
“In the same project, AD was the most prevalent pathology ( ≈ 65% of brains), followed by ischaemic infarcts, CAA, atherosclerosis, and arteriolosclerosis [146].”
Lopes, K. D. P., Vialle, R. A., Green, G., Fujita, M., Gaiteri, C., Menon, V., Schneider, J. A., Wang, Y., Jager, P. L. D., Habib, N., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02143-4 · Cited by 2
“Raw scores for individual tests were standardized using the baseline means and standard deviations of the entire cohorts, and then averaged across the tests to obtain the composite score [12, 60].”
Self-citationCognitions and chronic cerebrovascular disease (small vessel disease)
Oros, M. M. (2021) · INTERNATIONAL NEUROLOGICAL JOURNAL · doi:10.22141/2224-0713.17.5.2021.238526 · Cited by 1
The Harrington Discovery Institute and Alzheimer’s Disease Drug Development
Pieper, A. A., Mazza-Lunn, J. S., & Wetmore, D. R. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108975759.005 · Cited by 1
We are preventing some dementias now—But how? The Potamkin lecture
Hachinski, V., & Initiative, T. D. P. H. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12770 · Cited by 1
FDG PET Imaging Evaluation of Neurodegenerative Dementias
Minoshima, S., Thientunyakit, T., Cross, D. J., & Mosci, K. (2023) · Springer eBooks · doi:10.1007/978-3-031-35098-6_4 · Cited by 1
Dallaire‐Théroux, C., Smith, C., & Duchesne, S. (2024) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000200271 · Cited by 1
Intracerebral Hemorrhage and Cerebral Amyloid Angiopathy
Mayerhofer, E., Biffi, A., & Rosand, J. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-41777-1_11 · Cited by 1
VasCog 2023: 20 years of research on vascular behavioural and cognitive disorders
Gustafson, D. R., Kalaria, R. N., O'Brien, J. T., van den Brink, H., Hilal, S., Marseglia, A., ter Telgte, A., & Skoog, I. G. (2024) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2024.100224 · Cited by 1
Krivinko, J. M., Fan, P., Sui, Z., Happe, C. L., Hensler, C., Gilardi, J., Ikonomović, M. D., McKinney, B. C., Newman, J., Ding, Y., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02817-w · Cited by 2
Platelet Hyperactivity in Patients of Vascular Dementia
Dev, P., Ekhlak, M., Yadav, A. K., Dash, D., & Pathak, A. (2025) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-025-01867-7
BrightFocus Alzheimer’s Fast Track 2019
Whitaker, K. W., LaFerla, F. M., Steinbusch, H. W. M., Lemere, C. A., & Bovenkamp, D. E. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0348-y · Cited by 1
Clinical Topics in Old Age Psychiatry
Lilford, P., Adshead, G., & Hughes, J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714 · Cited by 1
Massetti, N., Granzotto, A., Bomba, M., Pizzi, S. D., Mosca, A., Scherer, R., ONOFRJ, M. C., Sensi, S. L., & (ADNI), F. T. A. D. N. I. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.119015 · Cited by 1
What Can Person-Centred Care in Dementia Learn from the Recovery Movement?
Hill, L., Roberts, G. A., & Perkins, R. E. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.018 · Cited by 1
Update FDG-PET in der Demenzdiagnostik
Buchert, R., & Förster, S. (2022) · Angewandte Nuklearmedizin · doi:10.1055/a-1712-6140 · Cited by 1
“Dabei ist die Möglichkeit der Koexistenz zweier oder mehrerer Pathologien in Betracht zu ziehen, umso mehr je älter der Patient ist [55].”
BackgroundAlzheimer disease biomarkers and synucleinopathy
Bennett, D. A., & Gordon, B. A. (2018) · Neurology · doi:10.1212/wnl.0000000000005171 · Cited by 1
Self-citationLaboratory diagnostics in dementia
Weber, T. (2018) · Journal of Laboratory Medicine · doi:10.1515/labmed-2018-0047 · Cited by 1
Considerations for trials of disease modifying treatments in Parkinson disease
Ahlskog, J. E. (2020) · Neurology · doi:10.1212/wnl.0000000000009127 · Cited by 1
“This study documented many seemingly random combinations of different brain neuropathologies in their 1,416 brain autopsies.(9) One infers from this that numerous, random combinations of neurodegenerative and vascular processes are a part of aging.”
BackgroundAsociaciones entre dieta y función cognitiva en el Proyecto SUN
Muñoz, M. I. (2022) · Deposito Adademico Digital Universidad De Navarra (University of Navarra) · doi:10.15581/10171/63292 · Cited by 1
A SCOPING REVIEW OF ALZHEIMER’S DISEASE HYPOTHESES: THE CASE FOR A MULTI-FACTORIAL THEORYPreprint
Duchesne, S., Rousseau, L., Belzile, F., Welsh, L.-A., Cournoyer, B., Arseneau, M., Lapierre, V., Poulin, S., Potvin, O., & Hudon, C. (2023) · medRxiv · doi:10.1101/2023.07.26.23293030 · Cited by 1
“looks at large post-mortem samples (8), meaning that amyloid is likely not the only aetiology”
Editorial: Brain health: risk, resilience and reserve
Kelly, M. E., Power, J. M., Parra, M. A., & Hannigan, C. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1386516 · Cited by 1
Xie, M., Eyting, M., Bommer, C., Ahmed, H., & Geldsetzer, P. (2024) · medRxiv · doi:10.1101/2024.08.23.24312457 · Cited by 1
Mental Health Laws from All UK Jurisdictions
Burrell, C., & Emmett, C. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.024
Neuropathology of Alzheimer’s Disease and Vascular Dementia
Kapasi, A., & Schneider, J. A. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780190634230.003.0015
Self-citationEpidemiology and Mental Health in Old Age
Lilford, P., & Hughes, J. C. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.004
Dementia or no dementia in the elderly. Why?
Kuller, L. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818000-6.00011-1
The reserve of brain: structure, modulators, capacity
Nikishkova, I. (2021) · Ukrains kyi Visnyk Psykhonevrolohii · doi:10.36927/2079-0325-v29-is2-2021-10
UT's Project Quest Reaches Deep into Instruction and Research
Danielson, W. A. (1988) · T.H.E. Journal Technological Horizons in Education
Mental Health in Parkinson’s Disease
Jones, S., Torsney, K., Scourfield, L., Berryman, K., & Henderson, E. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.011
Prevention of Age-Related Cognitive Impairment, Alzheimer’s Disease, and Dementia
Mangialasche, F., Kivipelto, M., Mecocci, P., & Ngandu, T. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_538
Mitchell, A. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.014
Hughes, J. C., Poole, M., Louw, S., Greener, H., & Emmett, C. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.026
Lilford, P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.028
Series, H. G., & Esiri, M. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.005
Hughes, J. C. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.003
Supporting Self-Management in Early Dementia
Cheffey, J., Hill, L., & Roberts, G. A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.017
Brindle, N., & Walsh, C. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.025
Colgate, R., Turner, A., & Rafferty, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.023
The Home Assessment in Old Age Psychiatry
Ng, B., & Atkins, M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.012
Jefferies, K., & Agrawal, N. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.006
Richards, F., & Curtice, M. J. R. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.008
Hughes, J. C., Jolley, D. J., Jordan, A., & Sampson, E. L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.020
Alcohol Misuse in Older People
Rao, R., & CROME, I. B. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.009 · Cited by 1
Wagle, A., & Badrakalimuthu, V. R. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.010
Reducing the Healthcare Burden of Delirium
Meagher, D. J., O'Connell, H. P., Cullen, W., & Adamis, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.022
Gupta, S., Fiertag, O., Thanulingam, T., Strange, B. A., & Warner, J. P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.007
Wilson, S., & Pinner, G. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.013
Hughes, J. C., & Lilford, P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.001
Biomarkers and the Diagnosis of Preclinical Alzheimer’s Disease
Lilford, P., & Hughes, J. C. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.015
Understanding the Person with Dementia
Hughes, J. C., & Beatty, A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.027
Hughes, J. C., & Lilford, P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.002
Sullivan, V., Majumdar, B., Richman, A. V., & Vinjamuri, S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.016
Abklärung der Alzheimer-Demenz – akademische Spielerei oder sinnvolle klinische Maßnahme?
Tatò, M., & Perneczky, R. (2022) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1769-1376
Prevention of Age-Related Cognitive Impairment, Alzheimer’s Disease, and Dementia
Mangialasche, F., Kivipelto, M., Mecocci, P., & Ngandu, T. (2020) · Springer eBooks · doi:10.1007/978-3-319-69892-2_538-1 · Cited by 1
Ashford, J. W. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734280398.793553881
Hughes, J. C., & Lilford, P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.029
Aged-Related Physiological Changes: CNS Function
Miot, S., Chancel, R., & Blain, H. (2022) · Lessons from the ICU · doi:10.1007/978-3-030-94133-8_3
Zotin, M. C. Z. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2022.tde-01122022-122130
Precision Nutrition and Cognitive Decline
Borut, P., Zalar, B., & Peterlin, A. (2022) · Springer eBooks · doi:10.1007/978-3-031-10153-3_8
Annoncer une maladie d’Alzheimer : pourquoi et comment ?
Meis, C., & Corvol, A. (2023) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2023.01.007
Cerebrolysin in the treatment of cognitive impairment
Bogolepova, A. N. (2023) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202312303120
Poonuru, R. R., Endla, S., Kazmi, T., Shaik, S., & Prasad, O. P. (2023) · Environmental Medicine · doi:10.26444/ms/172319
Cerebrovascular Lesion Loads and Accelerated Brain Ageing: Insights into the Cognitive SpectrumPreprint
Beheshti, I., Potvin, O., Dadar, M., Duchesne, S., & the CCNA Group (2023) · medRxiv · doi:10.1101/2023.10.04.23296558
Kietaibl, C. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1004882
Libon, D. J., Lamar, M., Swenson, R. A., & Heilman, K. M. (2020) · doi:10.1093/oso/9780190634230.002.0006
Acute Hemorrhagic Stroke and Neurocritical Care
Murali, T. (2024) · Springer eBooks · doi:10.1007/978-981-99-8059-8_52
Sundman, M., Green, J. M., Fuglevand, A. J., & Chou, Y. (2024) · Aging Brain · doi:10.1016/j.nbas.2024.100123
“Even when constrained to Alzheimer ’ s Disease (AD), the most common form of dementia biologically defined by amyloid-beta (A β ) plaques and neurofibrillary tau tangles, 9% of the 700 pathologically confirmed AD cases were absent of additional mixed pathologies [11].”
BackgroundRobbins, N. M., Bujarski, K. A., Stark-Laudate, A., Palladino, T., Bursey, J., Mason, S., Stommel, E. W., & Lawson, V. H. (2024) · RRNMF Neuromuscular Journal · doi:10.17161/rrnmf.v5i2.21478
Untangling the Genetic Threads of Alzheimer's: Insights into Risk Factors and Biomarkers
Naiyeri, A., Moqadami, A., & Khalaj‐Kondori, M. (2025) · Current Gene Therapy · doi:10.2174/0115665232338503241227111640
Anti-amyloid beta therapy resolves stroke recovery impairment caused by Alzheimer’s diseasePreprint
Sakai, S., Otani, K., Tsuyama, J., Hara, Y., Abe, K., Shimamura, T., Kawakami, I., Komori, T., Kawaji, H., Hase, K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.12.653388
Turner, D., Kamadasala, K., & McGarity, B. H. (2025) · Heart Lung and Circulation · doi:10.1016/j.hlc.2025.06.1027
Chronic Traumatic Encephalopathy and Traumatic Brain Injury
Asken, B. M., Perry, D. C., & Gardner, R. C. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108985055.019
Valacyclovir and Symptomatic Alzheimer Disease—No Evidence for Benefit
Knopman, D. S. (2025) · JAMA · doi:10.1001/jama.2025.20795
Stroke caused by cerebral amyloid angiopathy: a case of difficult diagnosis
Gamarra, R., Villanueva-Colina, C., & Garcia, J. P. (2025) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2025-0288
“The prevalence of CAA increases with age 3 and is higher in patients with a concomitant diagnosis of dementia 4 or Alzheimer disease 5 .”
Brown, J. L., Hart, D. W., Boyle, G. E., Brown, T. G., LaCroix, M., Baraibar, A. M., Pelzel, R. J., Kim, M., Sherman, M. A., Boes, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26554280
Chen, T.-B., Lee, W.-J., Chen, J.-P., Chang, S.-Y., Lin, C.-F., & Chen, H.-C. (2022) · Figshare · doi:10.6084/m9.figshare.21256971
Valenzuela, M., Duncan, T., Abey, A. S., Johnson, A., Boulamatsis, C., Dalton, M. A., Jacobson, E. E., Brunel, L., Child, G., Simpson, D., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20098303
Valenzuela, M., Duncan, T., Abey, A. S., Johnson, A., Boulamatsis, C., Dalton, M. A., Jacobson, E. E., Brunel, L., Child, G., Simpson, D., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20098306
Murray, J., Meloni, G., Cortes, E. P., KimSilva, A., Jacobs, M. M., Ramkissoon, A., Crary, J., & Morgello, S. (2022) · Figshare · doi:10.6084/m9.figshare.19728442
Rajab, M. D., Jammeh, E., Taketa, T., Brayne, C., Matthews, F. E., Su, L., Ince, P. G., Wharton, S. B., & Wang, D. (2024) · Figshare · doi:10.6084/m9.figshare.26574064
Brown, J. L., Hart, D. W., Boyle, G. E., Brown, T. G., LaCroix, M., Baraibar, A. M., Pelzel, R. J., Kim, M., Sherman, M. A., Boes, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26554283
ПРОГНОСТИЧЕСКАЯ СПОСОБНОСТЬ КОГНИТИВНОГО РЕЗЕРВА В ФОРМИРОВАНИИ СИНДРОМА МОТОРНО-КОГНИТИВНОГО РИСКА
Агарков, Н. М., Агаркова, В. Н., Лысенко, А. С., Мезенцев, Ю. А., Курзин, М. Л., Шарапов, И. Ю., Османов, Р. Э., & Ибиев, А. С. О. (2025) · Успехи геронтологии · doi:10.34922/ae.2025.38.4.004
Buchman, A. S., Yu, L., Oveisgharan, S., Tickotsky, N., Lopes, K. D. P., Zammit, A. R., VanderHorst, V., Klein, H.-U., Nag, S., & Bennett, D. A. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02971-7
“…the rate of cognitive decline and progressive parkinsonian signs were strongly related (Table S3), joint modeling also provides evidence that the combinations of pathologic PD and co-pathologies related to cognitive decline and progression of parkinsonian signs are different (Table 3) [18, 19].”
Self-citationMechanisms of Dural Involvement in Cerebral Amyloid Angiopathy
Zedde, M., Piazza, F., & Pascarella, R. (2025) · Cells · doi:10.3390/cells15010026
“CAA is also independently linked to cognitive decline, with autopsy findings of moderate-to-severe CAA correlating with accelerated cognitive decline in late life among community-dwelling individuals, even when considering Alzheimer’s disease and other neurodegenerative disorders [6].”
Wang, G., Zhao, Z., Guo, R.-N., & Qian, Z. (2026) · Computational and Theoretical Chemistry · doi:10.1016/j.comptc.2026.115678
Jenson, T. E., Andrews, R. M., Adar, S. D., Barnes, L. L., Bennett, D. A., Burnham, D., Cursio, J., Gassett, A. J., Graham, U. M., Kaufman, J. D., et al. (2026) · medRxiv · doi:10.64898/2026.02.03.26345515
Self-citationAge and the relation of common neuropathologies to dementia in Brazilian adultsPreprint
Farfel, J. M., Nag, S., Capuano, A. W., Sampaio, M. C. D. M., Poole, V. N., Wilson, R. S., & Bennett, D. A. (2026) · medRxiv · doi:10.64898/2026.02.11.26346038
Self-citationWheatley, S., Ferreira, D., Nordberg, A., Mohanty, R., & Westman, E. (2026) · Research Square · doi:10.21203/rs.3.rs-8910160/v1
Le rôle de la composante motrice dans les processus mnésiques des personnes agées
Karasinska, M. (2022) · theses.fr (ABES) · doi:10.70675/dc76e487z9aaaz4a84zb7f0z3c92232bd428
Lange‐Maia, B. S., Vialle, R. A., Wang, T., Zammit, A. R., Farfel, J., Seyfried, N. T., Bennett, D. A. A., & Buchman, A. S. (2026) · The Journals of Gerontology Series A · doi:10.1093/gerona/glag101
Self-citationTargeting Caspase-2 for the Treatment of Dementia
Walters, M. A., Pockes, S., & Ashe, K. H. (2026) · Topics in medicinal chemistry · doi:10.1007/7355_2026_192
Yasuda, S. M., Mock, C., Gauthreaux, K. M., Chan, K. Y. K., Keene, C. D., Culhane, J. E., Chen, Y., & Kukull, W. A. (2026) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlag033
Lo, T., Manousakis, J. E., Jackson, M. L., Woodward, M., Naismith, S. L., & Anderson, C. (2026) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887261452231
Patterson, C., Chattopadhyay, T., Thomopoulos, S. I., Saykin, A. J., Davatzikos, C. A., Mormino, E. C., Tosun, D., Beecham, G. W., Biber, S., Kukull, W. A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.2139/ssrn.6791127
Zedde, M., Basso, G., Piazza, F., & Pascarella, R. (2026) · Springer eBooks · doi:10.1007/978-3-032-23618-0_7
Metadata
- Authors
- Boyle, P. A., Yu, L., Wilson, R. S., Leurgans, S. E., Schneider, J. A., & Bennett, D. A.
- Affiliations
- Rush University Medical Center (US)
- Corresponding author
- Boyle, Patricia A.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2018-01
- Volume
- 83
- Issue
- 1
- Pages
- 74-83
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- PMC
- PMC5876116
- OpenAlex
- W2771599582
- Cited by
- 508
- References
- 26
- Citations by year
- 2026: 33 · 2025: 65 · 2024: 66 · 2023: 67 · 2022: 82 · 2021: 49 · 2020: 82 · 2019: 47 · 2018: 16
- FWCI
- 32.58
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH (R01AG34374, R01AG42210, R01AG17917, P30AG10161, R01AG15819)
- Illinois Department of Public Health
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- neuropathology, cognitive decline, dementia, Alzheimer's disease, Lewy bodies, hippocampal sclerosis, vascular pathology, neurodegenerative diseases, individual heterogeneity, aging
- MeSH terms
- Aged, Aged, 80 and over, Aging, Alzheimer Disease, Autopsy, Brain, Female, Humans, Longitudinal Studies, Male, Nervous System Diseases, Neuropsychological Tests, Dementia, Vascular, Cohort Studies, Comorbidity, Lewy Body Disease, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
